Effect of carbon monoxide donor CORM-2 on vitamin D3 metabolism

Kidney and Blood Pressure Research

Volumn 37, Issue 4-5, 2013, Pages 496-505

  Feger, Martina ^a   Fajol, Abul ^a   Lebedeva, Aleksandra ^a,b   Meissner, Adrian ^a   Michael, Diana ^a   Voelkl, Jakob ^a   Alesutan, Ioana ^a   Schleicher, Erwin ^a   Reichetzeder, Christoph ^c   Hocher, Berthold ^c   Qadri, Syed M ^a,d   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^c UNIVERSITY OF POTSDAM   (Germany)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

1,25 Dihydroxyvitamin D3; Calcium; CORM 2; FGF23; Klotho; Phosphate

Indexed keywords

CALCITRIOL; CALCIUM; CARBON MONOXIDE; CREATININE; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; MESSENGER RNA; PHOSPHATE; TRICARBONYLDICHLORORUTHENIUM II DIMER; UNCLASSIFIED DRUG; AGENTS AFFECTING METABOLISM; CALCIDIOL 1 MONOOXYGENASE; CALCIUM PHOSPHATE; COLECALCIFEROL 24 HYDROXYLASE; CYTOCHROME P450; CYTOCHROME P450 27B1; TRICARBONYL DICHLORORUTHENIUM DIMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYP27B1 GENE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; WESTERN BLOTTING; CALCIUM BLOOD LEVEL; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; FEMALE; MALE; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATE URINE LEVEL; REAL TIME POLYMERASE CHAIN REACTION; VITAMIN D METABOLISM;

ANIMALS; CARBON MONOXIDE; CELL LINE, TUMOR; CHOLECALCIFEROL; FEMALE; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; RATS; RUTHENIUM;

EID: 84890393932     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355730     Document Type: Article

References (78)

1. Haab P: The effect of carbon monoxide on respiration. Experientia 1990;46:1202-1206
2. Prockop LD, Chichkova RI: Carbon monoxide intoxication: An updated review. J Neurol Sci 2007;262:122- 130
3. Gullotta F, di Masi A, Coletta M, Ascenzi P: CO metabolism, sensing, and signaling. Biofactors 2012;38:1-13
4. Toyama T, Shinkai Y, Sumi D, Kumagai Y: Carbon monoxide derived from heme oxygenase-2 mediates reduction of methylmercury toxicity in SH-SY5Y cells. Toxicol Appl Pharmacol 2010;249:86-90
5. Loennechen JP, Nilsen OG, Arbo I, Aadahl P, Nilsen T, Waldum HL, Sandvik AK, Ellingsen O: Chronic exposure to carbon monoxide and nicotine: Endothelin ET(A) receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat. Toxicol Appl Pharmacol 2002;178:8-14
6. Motterlini R, Mann BE, Foresti R: Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Invest Drugs 2005;14:1305-1318
7. Rao D, Fechter LD: Protective effects of phenyl-N-tert-butylnitrone on the potentiation of noise-induced hearing loss by carbon monoxide. Toxicol Appl Pharmacol 2000;167:125-131
8. Thom SR, Ohnishi ST, Fisher D, Xu YA, Ischiropoulos H: Pulmonary vascular stress from carbon monoxide. Toxicol Appl Pharmacol 1999;154:12-19
9. Thom SR, Fisher D, Zhang J, Bhopale VM, Cameron B, Buerk DG: Neuronal nitric oxide synthase and N-methyl-D-Aspartate neurons in experimental carbon monoxide poisoning. Toxicol Appl Pharmacol 2004;194:280-295
10. Ahanger AA, Prawez S, Kumar D, Prasad R, Amarpal, Tandan SK: Wound healing activity of carbon monoxide liberated from CO-releasing molecule (CO-RM). Naunyn Schmiedebergs Arch Pharmacol 2011;384:93-102
11. Kim YM, Choi BM, Kim YS, Kwon YG, Kibbe MR, Billiar TR, Tzeng E: Protective effect of p53 in vascular smooth muscle cells against nitric oxide-induced apoptosis is mediated by up-regulation of heme oxygenase-2. BMB Rep 2008;41:164-169
12. Li MH, Cha YN, Surh YJ: Carbon monoxide protects PC12 cells from peroxynitrite-induced apoptotic death by preventing the depolarization of mitochondrial transmembrane potential. Biochem Biophys Res Commun 2006;342:984-990
13. Soni H, Patel P, Rath AC, Jain M, Mehta AA: Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: Role of coronary endothelium and underlying mechanism. Vascul Pharmacol 2010;68-76
14. Soni H, Pandya G, Patel P, Acharya A, Jain M, Mehta AA: Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: Role of oxidative stress and apoptosis. Toxicol Appl Pharmacol 2011;253:70-80
15. Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E, Helfrich W: Carbon monoxide-releasing molecule-2 (CORM- 2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol 2010;10:42
16. Johnson FK, Johnson RA: Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol 2003;285:R536-R541
17. Zhang F, Kaide JI, Rodriguez-Mulero F, Abraham NG, Nasjletti A: Vasoregulatory function of the heme-heme oxygenase-carbon monoxide system. Am J Hypertens 2001;14:62S-67S
18. Nielsen VG, Kirklin JK, George JF: Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma. Blood Coagul Fibrinolysis 2009;20:448-455
19. Nielsen VG, Kirklin JK, George JF: Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009;20:377-380
20. Winburn IC, Gunatunga K, McKernan RD, Walker RJ, Sammut IA, Harrison JC: Cell damage following carbon monoxide releasing molecule exposure: Implications for therapeutic applications. Basic Clin Pharmacol Toxicol 2012;111:31-41
21. Kajimura M, Fukuda R, Bateman RM, Yamamoto T, Suematsu M: Interactions of multiple gas-transducing systems: Hallmarks and uncertainties of CO, NO, and H2S gas biology. Antioxid Redox Signal 2010;13:157- 192
22. Pun PB, Lu J, Kan EM, Moochhala S: Gases in the mitochondria. Mitochondrion 2010;10:83-93
23. Yao P, Hao L, Nussler N, Lehmann A, Song F, Zhao J, Neuhaus P, Liu L, Nussler A: The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage. Am J Physiol Gastrointest Liver Physiol 2009;296:G1318-1323
24. Paulson SK, DeLuca HF: Subcellular location and properties of rat renal 25-hydroxyvitamin D3-1 alphahydroxylase. J Biol Chem 1985;260:11488-11492
25. Ingraham BA, Bragdon B, Nohe A: Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 2008;24:139-149
26. DeLuca HF: The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J 1988;2:224-236
27. Holick MF, Chen TC: Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-1086S.
28. Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, Eschmann R, Bals R: The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011;12:31
29. Tamez H, Thadhani RI: Vitamin D and hypertension: An update and review. Curr Opin Nephrol Hypertens 2012;21:492-499
30. Vuolo L, Di Somma C, Faggiano A, Colao A: Vitamin D and cancer. Front Endocrinol (Lausanne) 2012;3:58
31. Razzaque MS: FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies? Adv Exp Med Biol 2012;728:84-91
32. Kuro-o M: Endocrine FGFs and Klothos: Emerging concepts. Trends Endocrinol Metab 2008;19:239-245
33. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51
34. Alcaraz MJ, Guillen MI, Ferrandiz ML, Megias J, Motterlini R: Carbon monoxide-releasing molecules: A pharmacological expedient to counteract inflammation. Curr Pharm Des 2008;14:465-472
35. Lin TH, Tang CH, Hung SY, Liu SH, Lin YM, Fu WM, Yang RS: Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. J Cell Physiol 2010;222:757-768
36. Ackermann TF, Boini KM, Beier N, Scholz W, Fuchss T, Lang F: EMD638683, a novel SGK inhibitor with antihypertensive potency. Cell Physiol Biochem 2011;28:137-146
37. Tang C, Zelenak C, Volkl J, Eichenmuller M, Regel I, Frohlich H, Kempe D, Jimenez L, Le Bellego L, Vergne S, Lang F: Hydration-sensitive gene expression in brain. Cell Physiol Biochem 2011;27:757-768
38. Nasir O, Umbach AT, Rexhepaj R, Ackermann TF, Bhandaru M, Ebrahim A, Artunc F, Kempe DS, Puchchakayala G, Siraskar B, Foller M, Saeed A, Lang F: Effects of gum arabic (Acacia senegal) on renal function in diabetic mice. Kidney Blood Press Res 2012;35:365-372
39. Pathare G, Foller M, Daryadel A, Mutig K, Bogatikov E, Fajol A, Almilaji A, Michael D, Stange G, Voelkl J, Wagner CA, Bachmann S, Lang F: OSR1-sensitive renal tubular phosphate reabsorption. Kidney Blood Press Res 2012;36:149-161
40. Alesutan I, Daryadel A, Mohebbi N, Pelzl L, Leibrock C, Voelkl J, Bourgeois S, Dossena S, Nofziger C, Paulmichl M, Wagner CA, Lang F: Impact of bicarbonate, ammonium chloride, and acetazolamide on hepatic and renal SLC26A4 expression. Cell Physiol Biochem 2011;28:553-558
41. Pathare G, Foller M, Michael D, Walker B, Hierlmeier M, Mannheim JG, Pichler BJ, Lang F: Enhanced FGF23 serum concentrations and phosphaturia in gene targeted mice expressing WNK-resistant SPAK. Kidney Blood Press Res 2012;36:355-364
42. Dermaku-Sopjani M, Sopjani M, Saxena A, Shojaiefard M, Bogatikov E, Alesutan I, Eichenmuller M, Lang F: Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 2011;28:251-258
43. Pelzl L, Pakladok T, Pathare G, Fakhri H, Michael D, Wagner CA, Paulmichl M, Lang F: DOCA sensitive pendrin expression in kidney, heart, lung and thyroid tissues. Cell Physiol Biochem 2012;30:1491-1501
44. Voelkl J, Pasham V, Ahmed MS, Walker B, Szteyn K, Kuhl D, Metzler B, Alesutan I, Lang F: Sgk1-dependent stimulation of cardiac Na+/H+ exchanger Nhe1 by dexamethasone. Cell Physiol Biochem 2013;32:25-38
45. Martin A, David V, Quarles LD: Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 2012;92:131-155
46. Dai B, David V, Alshayeb HM, Showkat A, Gyamlani G, Horst RL, Wall BM, Quarles LD: Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites. Kidney Int 2012;82:1061-1070
47. Medici D, Razzaque MS, Deluca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro OM, Olsen BR, Lanske B: FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol 2008;182:459-465
48. Reiter CE, Alayash AI: Effects of carbon monoxide (CO) delivery by a CO donor or hemoglobin on vascular hypoxia inducible factor 1alpha and mitochondrial respiration. FEBS Open Bio 2012;2:113-118
49. Choi YK, Kim CK, Lee H, Jeoung D, Ha KS, Kwon YG, Kim KW, Kim YM: Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J Biol Chem 2010;285:32116-32125
50. Farrow EG, Yu XJ, Summers LJ, Davis SI, Fleet JC, Allen MR, Robling AG, Stayrook KR, Jideonwo V, Magers MJ, Garringer HJ, Vidal R, Chan RJ, Goodwin CB, Hui SL, Peacock M, White KE: Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA 2011;108:E1146-E1155
51. Clinkenbeard EL, Farrow EG, Summers LJ, Cass TA, Roberts JL, Bayt CA, Lahm T, Albrecht M, Allen MR, Peacock M, White KE: Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res 2013;10.1002/jbmr.2049
52. Forster RE, Jurutka PW, Hsieh JC, Haussler CA, Lowmiller CL, Kaneko I, Haussler MR, Kerr Whitfield G: Vitamin D receptor controls expression of the anti-Aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 2011;414:557-562
53. Csongradi E, Juncos LA, Drummond HA, Vera T, Stec DE: Role of carbon monoxide in kidney function: Is a little carbon monoxide good for the kidney? Curr Pharm Biotechnol 2012;13:819-826
54. Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ: Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2006;290:R601-R608
55. Asai O, Nakatani K, Tanaka T, Sakan H, Imura A, Yoshimoto S, Samejima K, Yamaguchi Y, Matsui M, Akai Y, Konishi N, Iwano M, Nabeshima Y, Saito Y: Decreased renal alpha-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int 2012;81:539-547
56. Cheng MF, Chen LJ, Cheng JT: Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats. J Biomed Biotechnol 2010;2010:513853
57. Zhao Y, Banerjee S, Dey N, LeJeune WS, Sarkar PS, Brobey R, Rosenblatt KP, Tilton RG, Choudhary S: Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 2011;60:1907-1916
58. Teran FJ, Johnson RA, Stevenson BK, Peyton KJ, Jackson KE, Appleton SD, Durante W, Johnson FK: Heme oxygenase-derived carbon monoxide promotes arteriolar endothelial dysfunction and contributes to salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2005;288:R615-R622
59. Kuwahara N, Sasaki S, Kobara M, Nakata T, Tatsumi T, Irie H, Narumiya H, Hatta T, Takeda K, Matsubara H, Hushiki S: HMG-CoA reductase inhibition improves anti-Aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. Int J Cardiol 2008;123:84-90
60. Carlberg C, Seuter S, Heikkinen S: The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res 2012;32:271-282
61. Fleet JC, DeSmet M, Johnson R, Li Y: Vitamin D and cancer: A review of molecular mechanisms. Biochem J 2012;441:61-76
62. Russell MA, Wilson C, Cole PV, Idle M, Feyerabend C: Comparison of increases in carboxyhaemoglobin after smoking "extra-mild" and "non-mild" cigarettes. Lancet 1973;2:687-690
63. Sen S, Peltz C, Beard J, Zeno B: Recurrent carbon monoxide poisoning from cigarette smoking. Am J Med Sci 2010;340:427-428
64. Brot C, Jorgensen NR, Sorensen OH: The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 1999;53:920-926
65. Vervloet MG, van Zuilen AD, Heijboer AC, ter Wee PM, Bots ML, Blankestijn PJ, Wetzels JF: Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort. BMC Nephrol 2012;13:20
66. Goldkorn T, Filosto S: Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol 2010;43:259-268
67. Ambrose JA, Barua RS: The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004;43:1731-1737
68. Rooney C, Sethi T: The epithelial cell and lung cancer: The link between chronic obstructive pulmonary disease and lung cancer. Respiration 2011;81:89-104
69. Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM: Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 2012;7:e38934
70. Cutillas-Marco E, Fuertes-Prosper A, Grant WB, Morales-Suarez-Varela M: Vitamin D deficiency in South Europe: Effect of smoking and aging. Photodermatol Photoimmunol Photomed 2012;28:159-161
71. Deeb KK, Trump DL, Johnson CS: Vitamin D signalling pathways in cancer: Potential for anticancer therapeutics. Nat Rev Cancer 2007;7:684-700
72. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M: Suppression of aging in mice by the hormone Klotho. Science 2005;309:1829-1833
73. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, Malide D, Rovira, II, Schimel D, Kuo CJ, Gutkind JS, Hwang PM, Finkel T: Augmented Wnt signaling in a mammalian model of accelerated aging. Science 2007;317:803-806
74. Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, Shiizaki K, Gotschall R, Schiavi S, Yorioka N, Takahashi M, Boothman DA, Kuro-o M: Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 2011;286:8655-8665
75. Abramovitz L, Rubinek T, Ligumsky H, Bose S, Barshack I, Avivi C, Kaufman B, Wolf I: KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer. Clin Cancer Res 2011;17:4254-4266
76. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, Kuro-o M, Karlan B, Kaufman B, Koeffler HP, Rubinek T: Klotho: A tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 2008;27:7094-7105
77. Chen B, Ma X, Liu S, Zhao W, Wu J: Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner. Cancer Biol Ther 2012;13:1221-1228
78. Usuda J, Ichinose S, Ishizumi T, Ohtani K, Inoue T, Saji H, Kakihana M, Kajiwara N, Uchida O, Nomura M, Ohira T, Ikeda N: Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery. Lung Cancer 2011;74:332-337